Reporting from the frontiers of health and medicine

Biostatistics and bioinformatics shape Africa’s genomics policy

Biostatistics and bioinformatics shape Africa’s genomics policy GenoMethods.org © genomethods.org
Biostatistics and bioinformatics shape Africa’s genomics policy © genomethods.org
Africa’s labs are awash in genomic data, but Wafaa Rashed and Mutaz M Abdallah say only local expertise in biostatistics and bioinformatics can turn that data into fair, effective policy.

In African research labs, the numbers keep climbing. Genomic data pours in by the millions. But raw data alone does not change lives. Wafaa Rashed, who leads the Pan-African PGS Education and Research Initiative, puts it plainly. Africa needs more than numbers. It needs sharp analysis and local voices at the table. Policy must be built by Africans, for Africans.

Mutaz M. Abdallah, a graduate of Rashed’s initiative, is not staying quiet. His latest blog, “From Data to Decisions: The Critical Role of Biostatistics and Bioinformatics in Genomics Policy Development,” asks a tough question. How do we turn endless sequences into evidence that leaders can trust?

African genomic data remains significantly underrepresented in global databases, raising concerns about data sovereignty and the need for local infrastructure.

Business & Actuality TV

Abdallah’s answer is clear. Bioinformatics sorts, processes, and makes sense of complex genomic data. Biostatistics tests which results hold up and which do not. These fields drive disease tracking, genetic screening, and public health plans. Without them, data is just noise.

But Abdallah goes further. He says equity and real representation must be at the core of Africa’s genomics policy. Are African people truly included in global databases? Do genetic tests work for all groups on the continent? Are African scientists and communities making decisions about their own data? These are not just theory. They decide who benefits—and who gets left out.

Rashed backs this up. She points to privacy, ethical rules, cost, local skills, and public trust. These are not extras. They are the basics for any responsible genomics policy. Africa cannot just follow global trends. It must build its own systems, rules, and partnerships. Only then will new discoveries help real people on the ground.

The World Health Organization has developed a genomics costing tool to help countries budget for routine sequencing and bioinformatics, covering everything from infrastructure and reagents to workforce and quality assurance.

World Health Organization

This push for local control is not unique. Other big genomics projects have hit roadblocks, as seen in recent gene editing delays. The lesson is simple. Without strong methods and local context, even the best data can stall.

Rashed and Abdallah are not asking for handouts or token seats. They want a future where Africa builds its own expertise, sets its own rules, and forms real partnerships. The next leap in African genomics will not come from more data alone. It will come from building skills, setting ethical standards, and working together. That is how policy becomes real. That is how it serves the people who need it most.

A recent expert review found that next-generation sequencing (NGS) infrastructure in Africa grew quickly after COVID-19. But real progress is still blocked by funding gaps, too few trained staff, and not enough bioinformatics know-how. The review makes it clear: biostatistics and bioinformatics are not optional. They are the tools that turn big data into real health policy. Rashed and Abdallah’s arguments stand on solid ground.

South Africa shows how tough the rules can be. The Protection of Personal Information Act (POPIA) tightly controls how sensitive data is used in research. It usually bans processing special personal data, except for research, statistics, or history. Sending medical data across borders may need approval from the Information Regulator. The National Health Research Ethics Council explains why strong data rules matter for African genomics. The stakes are high.

Adrian Cole Founder, bioengineering editor and methods specialist GenoMethods.org
Biotechnology Newsroom

Adrian Cole

Adrian Cole is the Founder and Editor-in-Chief of GenoMethods, where he writes about bioengineering, genome and cell engineering, synthetic biology, computational biology and emerging research methods. His editorial approach focuses on how technologies actually work, how they are validated and where the evidence stops supporting the claim.